Sunday Night

2014-10-12 (2014x34)

Fecha de emisión: Oct 12, 2014

Secrets and Lies: A Worldwide Investigation Stephen Fry Secrets and Lies: A Worldwide Investigation This major worldwide investigation by Sunday Night lifts the lid on a scandal that defies belief. How could one of the world’s biggest pharmaceutical companies ignore for decades the potentially lethal side-effects to patients from one of its most profitable drugs? But that is exactly what happened here in Australia and around the world. Thousands of patients died after taking Trasylol – a drug used by surgeons to prevent excessive bleeding and save the need to give blood transfusions. Operations appeared to be successful, but people suffered heart attacks, strokes or severe kidney damage – and many of those who didn’t die were left facing a lifetime on dialysis. Trasylol cost $1,000 a dose and was used across Australia at major hospitals for two decades before it was approved by the TGA, and another 15 years before it was finally taken off the market. Mounting medical evidence about the human toll from Trasylol was ignored by the company, which even withheld its own bombshell research from drug regulators. Chief investigations reporter Ross Coulthart meets the courageous Australian nurse who vowed as a young child to find out what happened to her super fit father, who died suddenly following a routine operation in 1978. It took her more than 30 years but when Jenny finds out the truth about her dad being given Trasylol she travels to Germany for an extraordinary face-to-face showdown with the bosses of the drug company that made it, and then hid its deadly secret. Tens of thousands of Australian families who lost a loved one to stroke, heart attack or kidney failure will not realise the cause of their pain and loss could be Trasylol. There is only one thing they can do to find the truth. In the United States, thousands of law suits have been launched, and the drug company has paid out hundreds of millions of dollars. But here in Australia, not one cent